CN105232907A - 一种补肾壮阳饮料及其制备方法 - Google Patents
一种补肾壮阳饮料及其制备方法 Download PDFInfo
- Publication number
- CN105232907A CN105232907A CN201510773980.3A CN201510773980A CN105232907A CN 105232907 A CN105232907 A CN 105232907A CN 201510773980 A CN201510773980 A CN 201510773980A CN 105232907 A CN105232907 A CN 105232907A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- kidney
- fructus
- kidney invigorating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 89
- 235000013361 beverage Nutrition 0.000 title claims abstract description 35
- 238000005728 strengthening Methods 0.000 title abstract description 13
- 238000000034 method Methods 0.000 title abstract description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 51
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 50
- 235000008434 ginseng Nutrition 0.000 claims abstract description 50
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 29
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 29
- 235000021014 blueberries Nutrition 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 22
- 244000268590 Euryale ferox Species 0.000 claims abstract description 21
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 20
- 210000000582 semen Anatomy 0.000 claims abstract description 20
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 14
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 14
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000001630 malic acid Substances 0.000 claims abstract description 14
- 235000011090 malic acid Nutrition 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 14
- 239000000811 xylitol Substances 0.000 claims abstract description 14
- 229960002675 xylitol Drugs 0.000 claims abstract description 14
- 235000010447 xylitol Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 230000008093 supporting effect Effects 0.000 claims description 32
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 22
- 240000006108 Allium ampeloprasum Species 0.000 claims description 22
- 239000009636 Huang Qi Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 17
- 241000271571 Dromaius novaehollandiae Species 0.000 claims description 16
- 241000190633 Cordyceps Species 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000002372 labelling Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 230000033228 biological regulation Effects 0.000 claims description 5
- 238000000265 homogenisation Methods 0.000 claims description 5
- 238000007689 inspection Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims 5
- 230000000694 effects Effects 0.000 abstract description 47
- 230000006870 function Effects 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 8
- 235000016709 nutrition Nutrition 0.000 abstract description 8
- 230000036299 sexual function Effects 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 5
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 235000018645 Allium odorum Nutrition 0.000 abstract 1
- 244000003377 Allium tuberosum Species 0.000 abstract 1
- 235000005338 Allium tuberosum Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001165494 Rhodiola Species 0.000 abstract 1
- 241001247821 Ziziphus Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 description 46
- 239000008280 blood Substances 0.000 description 32
- 210000004369 blood Anatomy 0.000 description 30
- 210000004185 liver Anatomy 0.000 description 22
- 230000007812 deficiency Effects 0.000 description 19
- 241000282414 Homo sapiens Species 0.000 description 17
- 210000000952 spleen Anatomy 0.000 description 15
- 239000003814 drug Substances 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 230000036039 immunity Effects 0.000 description 8
- 230000001568 sexual effect Effects 0.000 description 8
- 244000077233 Vaccinium uliginosum Species 0.000 description 7
- 201000001881 impotence Diseases 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 150000004804 polysaccharides Chemical class 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 229930182494 ginsenoside Natural products 0.000 description 6
- 229940089161 ginsenoside Drugs 0.000 description 6
- 230000036737 immune function Effects 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000003014 reinforcing effect Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 229930014669 anthocyanidin Natural products 0.000 description 5
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 5
- 235000008758 anthocyanidins Nutrition 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- -1 antiseptic Substances 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000010228 Erectile Dysfunction Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- 235000008935 nutritious Nutrition 0.000 description 4
- 206010036596 premature ejaculation Diseases 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 102000004330 Rhodopsin Human genes 0.000 description 2
- 108090000820 Rhodopsin Proteins 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 201000002313 intestinal cancer Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000037209 prostate health Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 235000016804 zinc Nutrition 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical class NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- YHQXBTXEYZIYOV-UHFFFAOYSA-N 3-methylbut-1-ene Chemical group CC(C)C=C YHQXBTXEYZIYOV-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000208421 Ericaceae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020802 Hypertensive crisis Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000000501 Lipidoses Diseases 0.000 description 1
- 206010024585 Lipidosis Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- SKPPEIDJGJGRGK-UHFFFAOYSA-N Panacen Natural products CCC1=CC=CC2=C1C1OC(C=C=CBr)CC1O2 SKPPEIDJGJGRGK-UHFFFAOYSA-N 0.000 description 1
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 208000008601 Polycythemia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 108010046685 Rho Factor Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000004301 Sinus Arrhythmia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 241000736767 Vaccinium Species 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000011279 abdominal lump Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000012059 diaphragm disease Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003236 psychic effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 208000003663 ventricular fibrillation Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种补肾壮阳饮料,是由如下重量份数的原料组成的:蓝莓10-30份、红枣8-20份、鸸鹋阳5-20份、枸杞子10-30份、人参5-20份、山药10-25份、肉桂10-30份、芡实5-15份、韭菜籽10-30份、红景天10-30份、女贞子10-40份、鸡血藤10-30份、鹿茸10-30份、杜仲10-35份、黄芪10-30份、当归10-40份、何首乌10-30份、冬虫夏草5-20份、木糖醇5-30份、苹果酸5-20份、纯净水26-150份。本发明还提供补肾壮阳饮料的制备方法,在保留物质营养成分和保健功能的基础上进行加工,具有生产工艺简单、成品品质比较稳定的特点,原料中的营养物质起到协同增效的作用,营养更加丰富,口感更细腻,具有增强体力,增强性功能的功效。
Description
技术领域
本发明涉及保健品技术领域,尤其涉及一种补肾壮阳饮料及其制备方法。
背景技术
社会的进步和经济的快速发展,必然给人们,尤其是男人带来较大的家庭及社会压力。35-55岁年龄段的男性是家庭及社会的主导力量,长期高负荷的工作导致大多数人身体处于亚健康状态。此外,年龄的增加也导致新陈代谢能力下降。两者必然导致肾虚、性功能及免疫能力下降。因此,改善中年男性人群的身体健康,采用以药食同源为主的食品进行食疗,使他们恢复及保持良好的肾、性及免疫能力具有迫切性。
中医认为肾在人的身体上是十分重要的器官,人的许多疾病如性功能方面的障碍等都与肾的功能密切相关。目前市场上补肾壮阳的药物种类繁多,但大多都在使用后有一定的副作用,并且从口感营养成分及功效上比较单一。
传统的饮料主要采用甜味剂、酸味剂、香精、稳定剂、防腐剂等原辅料,很多成分为人工合成,对人体的健康带来安全隐患。虽然含有果汁、白砂糖等成分,仅仅满足人体的部分营养需求,很少有针对中年男性人群开发出具有保健功能的饮料。因此,亟需开发一种药效好、口感佳、保健效果显著的补肾壮阳饮料,以满足人们的需求。
发明内容
本发明的目的在于提供一种营养丰富,具有保健功效,生产工艺简单,成品的品质稳定的补肾壮阳饮料及其制备方法。
为实现本发明的上述目的,本发明提供一种补肾壮阳饮料,是由如下重量份数的原料组成的:蓝莓10-30份、红枣8-20份、鸸鹋阳5-20份、枸杞子10-30份、人参5-20份、山药10-25份、肉桂10-30份、芡实5-15份、韭菜籽10-30份、红景天10-30份、女贞子10-40份、鸡血藤10-30份、鹿茸10-30份、杜仲10-35份、黄芪10-30份、当归10-40份、何首乌10-30份、冬虫夏草5-20份、木糖醇5-30份、苹果酸5-20份、纯净水26-150份。
本发明还提供一种补肾壮阳饮料的制备方法,包括如下步骤。
步骤1、按配方比例将蓝莓、红枣、鸸鹋阳、枸杞子、人参、山药、肉桂、芡实、韭菜籽、红景天、女贞子、鸡血藤、鹿茸、杜仲、黄芪、当归、何首乌、冬虫夏草、木糖醇混合,得原料混合物。
步骤2、向原料混合物中加入纯净水进行均质,均质后过滤(300目)。
步骤3、向过滤后的混合液中加入苹果酸,调节体系的pH值为6.0-6.8。
步骤4、在125℃的温度下进行灭菌,然后降温至30-40℃灌装,最后用微波二次灭菌,检质,贴标,装箱。
所述步骤2中的纯净水温度为65-70℃。
所述步骤2中均质压力为25-35Mpa。
在本发明组方中。
蓝莓:属杜鹃花科,越橘属植物。其功效为:(1)保护视力,消除疲劳。蓝莓中含有丰富的“花青素”,是维护眼睛健康、预防视力受损的重要元素,其功能在于保护眼睛的微血管,进而促进血液循环;同时更有加速视紫质朴再生的能力,而视紫质朴正是良好的视力不可或缺的东西。(2)预防疾病。蓝莓含有丰富的花青素。美国的一份研究报告指出,蓝莓含有的花青素是所有的水与蔬菜之中含量最高的,而且蓝莓的花青素最丰富的部分就是在它特有的紫色果皮部位。花青素对血管硬化、心脏疾病、减缓衰老,增强记忆力都有显著功效,尤其可以增加胶原蛋白,可降低眼压,缓解眼睛疲劳,有益于青光眼和白内障。蓝莓吸收自由基的能力(ORAC值)很高,可以减少氧自由基对细胞膜、DNA(又称脱氧核糖核酸,是颜色太的主要化学成分,同时也是组成基因的材料,有时被称为“遗传微粒”。)和其它的细胞成分的损害,预防体内功能紊乱和许多老年疾病的发生。(3)营养丰富。蓝莓果实营养丰富。据测定,每百克蓝莓鲜果中含蛋白质400-700毫克、脂肪500-600毫克、碳水化合物12.3-15.3克、维生素A高达81-100IU(国际单位),除含有常规的糖、酸、维生素C、矿物元素外,蓝莓果实中还含有尼克酸、SOD((超氧化物歧化酶)是一种源于生命体的活性物质,能消除生物体在新陈代谢过程中产生的有害物质;对人体不断地补充SOD具有抗衰老的特殊效果)、黄酮(黄酮类化合物泛指两个具有酚烃基的苯环(A-与B-环)通过中央三碳原子相互连接而成的一系列化合物黄酮类化合物结构中常连接有份羟基、甲氧基、甲基、异戊烯基等官能团。此外,它还常与糖结合成苷。)等特殊成分。由此可见,蓝莓果实不仅是具有良好的防脑神经老化、强心、抗癌等保健作用,而且是营养丰富的果品。蓝浆果还是一种高纤维食品,根据USDA的数据,145g蓝浆果中至少含有2.9g纤维,因此可以作为日常饮食中纤维的良好来源。蓝浆果还是一种低热量的食品,1/2杯蓝浆果仅含42卡路里的热量。(4)增强与防止。增强人体免疫力,助眠,激活人体细胞、促进微循环、延缓衰老、防止心脑血管发生病变。抗氧化,对人体上皮细胞有增生作用,从而可以达到美容养颜之功效。具有抗溃疡、抗炎、润面之功能,可预防早期肠癌。祛风除湿、强筋骨、滋阴补肾,提高人体活力。
红枣:①抗癌:枣能提高人体免疫力,并可抑制癌细胞,能促进白细胞的生成,降低血清胆固醇,提高血清白蛋白,保护肝脏,红枣中还含有抑制癌细胞,甚至可使癌细胞向正常细胞转化的物质。②降血压、降胆固醇。红枣中的维生素P含量为所有果蔬之冠,其具有维持毛细血管通透性,改善微循环,从而预防动脉硬化的作用。还可以调节人体代谢增强免疫力、抗炎、抗变态反应、降低血糖和胆固醇含量等作用,所含芦丁有保护毛细血管通畅,防止血管壁脆性增加。③保肝护肝。红枣能提高体内单核细胞的吞噬功能,有保护肝脏、增强体力的作用;红枣中的维生素C能减轻化学物对肝脏的损害,并可促进蛋白质合成,增加血清总蛋白含量的作用。
鸸鹋阳:鸸鹋的蛋,含有20多种矿物质及人体必需的微量元素,其中多种微量元素是维持男性性功能所必需的营养成分,对刺激男性激素分泌,促进血循环,提高男性机体活力具有十分独特的作用。其中,硼:维持前列腺健康;钙:让男性骨髓硬朗;硒:有助于男性抗癌;锌:维持前列腺健康,防治前列腺疾患的重要物质。
枸杞子:性甘、平、归肝肾经,具有滋补肝肾,养肝明目的功效;能壮阳,防治疾病,降血压,降血糖,降血脂。
人参:味甘、微苦,性温、平;归脾、肺经、心经。其功效为:(1)调节中枢神经系统。人参能调节中枢神经系统,改善大脑的兴奋与抑制过程,使之趋于平衡;能提高脑力与体力劳动的能力,提高工作效率,并有抗疲劳的作用。(2)促进大脑对能量物质的利用,可以提高学习记忆能力。人参中增强学习和记忆能力的有效成分为人参皂苷,其中人参皂苷Re1和Rg1,对学习和记忆功能均有良好影响。人参根皂苷对正常大鼠学习。记忆过程有促进作用,而人参静叶皂苷对电休克所致的大鼠记忆障碍有明显的改善作用。两者均使正常大鼠不同脑区的单胺类递质含量明显增多。这些研究工作,对合理应用人参植物资源有一定参考价值。(3)改善心脏功能。人参能增加心肌收缩力,减慢心率,增加心输出量与冠脉血流量,可抗心肌缺血与心律失常。对心脏功能、心血管、血流都有一定的影响。人参有明显的耐缺氧作用,其制剂可有效地对抗窦性心律失常。人参皂苷可加快脂质代谢,并具有明显降低高胆固醇的作用。不同的人参制剂对离体蟾蜍心脏及在体兔、猫、犬心脏皆有增强其功能的作用,并可改善其心室纤颤时的心肌无力。(4)降血糖作用。人参中含有人参皂苷和人参多糖。尤其是人参皂苷Rb2有明显的降血糖作用,此外人参多糖(或糖肽类)是人参中另一类降血糖成分。(5)增强机体的免疫功能。人参皂苷和人参多糖是人参调节免疫功能的活性成分,不但对正常人,而且对免疫功能低下的人均有提高免疫功能作用。人参多糖是人参中提纯的高分子酸性多糖,是一种免疫增强剂。经过动物实验和人体临床实验观察,证实能显著增强人体免疫力,对恶性肿瘤有一定疗效;临床实验可见同样延长病人生存时间,提高机体细胞免疫功能,且减轻放疗的毒副作用,加快损伤组织的修复。经过临床观察证实:人参多糖有明显的升白细胞作用,与放化疗同时应用,能够减小放疗的毒副作用,预防白细胞减少使病人顺利的完成治疗。应用人参多糖过程中无副作用,证明该药是安全、可靠的。(6)提高对有害刺激的抵御能力,可增强机体的应激能力和适应性。人参中含有人参苷,可以提高抗应激作用。可以抗缺氧、耐高温和低温的能力。(7)抗肿瘤作用。人参中皂苷、人参多糖、人参烯醇类、人参炔三醇和挥发油类物质。这些物质对肿瘤有一定的抑制作用,但是机理是十分复杂的。(8)抗氧化作用。人参中含有多种抗氧化物质,人参皂苷、人参聚乙炔类化合物和人参二醇皂苷等。这些化合物有抗脂质过氧化作用,是抗衰老作用的基础。除了抗衰老作用外,对神经、内分泌、免疫功能及物质代谢等生理功能有调节作用。此外,人参还具有抗病毒、抗休克、减肥等多方面的作用。人参虽然是价值较高的补品,但并非人人适用。人参中的蛋白质因子能抑制脂肪分解,加重血管壁脂质沉积,故有冠心病、高血压、脑血管硬化、糖尿病、脉管炎害应慎服人参。血液黏稠度升高,会使血液流通不畅,中医称之为血瘀。人参有促进红细胞生长的作用,红细胞增多,血液站稠度会更高。人参有中枢神经兴奋作用,它会使失眠者大脑皮层兴奋与抑制平衡失调,加重失眠。现已查明,很多胃病的罪魁祸首是幽门螺旋杆菌,而人参对该病菌有保护作用,不利于药物对它的杀灭。人参有类雌激素样作用,能抑制胆道排泄胆汁使胆汁变稠。调查证明,长期服人参害胆结石发病率明显升高。人参比较安全,但用量过大会产生“人参滥用综合征”等不良反应,故应慎用:①心血管系统:对冠状动脉、脑血管、眼底血管均有扩张作用,可引起心悸、血压升高,甚至发生高血压危象以及出血等症状,亦有少数人表现为低血压;②神经系统:可引起中枢神经兴奋和刺激症状;③消化系统:可见恶心、呕吐,严重的可引起上消化道出血;④水、电解质代谢:口服能产生抗利尿作用,与去氧皮质醇作用相似;⑤过敏反应:可引起面部及全身皮肤潮红、丘疹、瘙痒等过敏症状。
山药:甘、平、无毒;归脾、肺、肾经。其功效为:有效改善高血糖,山药中的黏滑成分也是有黏蛋白形成的。粘蛋白能包裹肠内的其他食物,使糖分被缓慢地吸收。这一作用能抑制饭后血糖急剧上升,同时也可以避免胰岛素分泌过盛,是血糖得到较好的调控。山药还含有胰岛素分泌必不可少的镁和锌等有效成分,以及维生素B1、维生素B2,这些成分崔静了血液中葡萄糖的代谢。此外,山药还含有淀粉酶,这是消化糖类的酶,可使血液中不再积存糖分。
红景天:益气活血、通脉平喘,用于气虚血瘀,胸痹心痛,中风偏瘫,倦怠气喘。具有抗缺氧、抗疲劳、增强耐力、抗菌等药用功效。
女贞子:益肝肾,清虚热,明目。主治头昏目眩,腰膝酸软,遗精,须发早白,骨蒸潮热,目暗不明,肝肾阴虚。
鸡血藤:补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛。
鹿茸:味甘,咸,温,归肾、肝经。有壮肾阳,补遗精,强筋骨,调冲任,抗疮毒。主治肾虚,头昏,耳聋,目暗,阳痿,滑精,宫冷不孕,赢瘦,神疲,畏寒,腰脊冷痛,筋骨痿软,崩漏带下,阴疽不敛及久病虚损等症。
何首乌:有补肝肾,益精血的作用,历代医家均用之于肾虚之人。明李时珍:“何首乌能养血益肝,固精益肾,健筋骨,乌鬓发,为滋补良药,功在地黄天门冬储药之上”。
杜仲:性温,味甘微辛,能补肾强筋骨,对肾虚所致的腰脊酸痛,足膝柔软无力,小儿肾虚,两下肢麻痹以及妇女肾亏引起的习惯性流产者最为适宜。正如明代医家缪希维解释说:“杜仲主腰脊痛,益精气,坚筋骨,脚中酸痛。盖腰为肾之府,动摇不能,肾将备矣。杜仲补其不足,益肾故也。
黄芪:有益气、固本、敛汗,生肌、利水、消水肿等。用于治疗气虚乏力,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴,慢性肾炎,蛋白尿、糖尿病等。
当归:性温,味甘辛。归心肝,脾经。补血和血,调经止痛,润燥滑肠。治月经不调,经闭腹痛,症瘕结聚,崩漏,血虚头痛,眩晕,瘘痹,肠燥便难。补血:能显著促进机体造血功能,升高红细胞,白细胞和血红蛋白含量。调血脂:抑制血小板凝聚,抗血栓,调节血脂。降血压:抗心肌缺血、心律失常,扩张血管,降低血压。增强免疫力:增强免疫、抗炎、保肝、抗辐射、抗氧化和清除自由基等。
肉桂:为樟科植物肉桂的干燥树皮。味辛、甘,性大热;归肾、脾、心、肝经。其功效为:补元阳,暖脾胃,除积冷,通血脉。治命门火衰,肢冷脉微,亡阳虚脱,腹痛泄泻,虚阳浮越。
芡实:为睡莲科植物芡的干燥成熟种仁。性平,味甘涩,归脾、肾经。有益肾固涩,补脾止泄的双重功效。《本草经百种录》称之为“脾肾之药也。”《本草从新》亦说它能“补脾固精”。《本草新编》中还说:“芡实不特益精,且能涩精补肾,与山药并用,各为末,日日半饭调服。”凡肾虚之人遗精,早泄,带下,小便不禁或频多者通常食之。
韭菜籽:为百合科植物韭菜的干燥成熟种子。辛、甘、温;归肾、肝经。功效为补肝肾,暖腰膝,助阳,固精。主要用于阳痿、早泄、遗精、遗尿小便频数、腰膝酸软、冷痛、白带过多等症的治疗。现代医学通过科学分析,认为韭菜籽具有如下保健功效:补肾温阳;韭菜籽性温,味辛,具有补肾起阳的作用,故可用于治疗阳痿、遗精、早泄、等病症;益肝健胃;韭菜籽含有挥发性精油及硫化物等特殊成分,散发出一种独特的辛香气味,有助于疏调肝气,增进食欲,增强消化功能;行气理血:韭菜籽的辛辣气味有散瘀活血,行气导滞作用,适用于跌打损伤,反胃、肠炎、吐血、胸痛等症;润肠通便:韭菜籽含有大量维生素和粗纤维,能增进胃肠蠕动,治疗便秘,预防肠癌。
冬虫夏草:性温,味甘,其功效为:补虚损,益精气,止咳化痰。治痰饮喘嗽,虚喘,痨嗽,咯血,自汗盗汗,阳痿遗精,腰膝酸痛,病后久虚不复。《本草从新》保肺益肾,止血化痰,已劳嗽。《药性考》秘精益气,专补命门。《柑园小识》以酒浸数枚啖之,治腰膝间痛楚,有益肾之功。《纲目拾遗》潘友新云治膈症,周兼士云治盅胀。《现代实用中药》适用于肺结核,老人衰弱之慢性咳嗽气喘,吐血、盗汗、自汗;又用于贫血虚弱,阳痿遗精,老人胃寒,涕多泪出等症。《云南中草药》补肺、壮肾阳。治痰次喘咳。
本发明组方的配伍释义:中医认为:“肾为先天之本”,“肾藏精,主生长、发育、生殖”,“肾主骨,生髓通脑”,“肾主纳气,肾主水液”,“肾开窍于耳”,“肾司二便”,“腰为肾之府”,因此,肾脏的健康说明人体生长、发育、生殖系统的活力。红枣、人参合用,人参能益气健脾,红枣能健脾和胃,对慢性肾功能不全病人,贫血者,有提高血红蛋白的作用。红枣、当归、何首乌、枸杞子配伍合用,具有补肝肾,益气血之功效。首乌养肝肾补血,当归养血和血,枸杞子补肝肾,明目。红枣、黄芪、当归、山药配伍有益气血、补虚损之功效。红枣、红景天、枸杞配伍,能促进人体自身调节,还有抗疲劳及促进性功能的作用。鸡血藤配杜仲,补肾壮骨通经止痛。鸡血藤配当归能补血。女贞子、枸杞子、何首乌配伍治疗腰膝酸软。红景天、黄芪、芡实、杜仲可保护肾脏、健脾补肾之功效。芡实配山药:芡实能涩精补肾,与山药并用,凡肾虚之人,遗精早泄,带下,小便不禁或频多者,宜常食之。肉桂与人参、黄芪合用,能够除肝肾脾内虚火,补充元气。韭菜籽与枸杞子配伍,用于补肾益精、滋阴补阳、养肝明目、固精止遗等。韭菜籽加山药,具有补肾益肾填精,补肺健脾的作用。本发明采用十八种中药合用,有补血、益气、益精、健肝、肺、脾,壮骨通经,滋阴壮阳之功效。
与现有技术相比本发明的有益效果。
本发明提供的补肾壮阳饮料及其制备方法,根据中医肾为先天之本的理论,以补肾壮阳为主,选材精细,配伍合理,在保留了蓝莓、红枣、鸸鹋阳、枸杞子、人参、山药、肉桂、芡实、韭菜籽、红景天、女贞子、鸡血藤、鹿茸、杜仲、黄芪、当归、何首乌、冬虫夏草的营养成分和保健功能的基础上,将十八种物质进行加工,具有生产工艺简单、成品品质比较稳定的特点,它们中的营养物质起到协同增效的作用,营养更加丰富,口感更细腻,具有增强体力,增强性功能的功效。
附图说明
图1为本发明补肾壮阳饮料的制备方法流程图。
具体实施方式
下面结合具体实施例进一步详细说明本发明。
实施例1。
本实施例1提供一种补肾壮阳饮料,是由如下重量份数的原料组成的:蓝莓10份、红枣8份、鸸鹋阳5份、枸杞子10份、人参10份、山药10份、肉桂10份、芡实8份、韭菜籽10份、红景天10份、女贞子10份、鸡血藤10份、鹿茸10份、杜仲10份、黄芪10份、当归10份、何首乌10份、冬虫夏草8份、木糖醇10份、苹果酸8份、纯净水95份。
请参阅图1,本实施例1还提供一种补肾壮阳饮料的制备方法,包括如下步骤。
步骤1、按配方比例将蓝莓、红枣、鸸鹋阳、枸杞子、人参、山药、肉桂、芡实、韭菜籽、红景天、女贞子、鸡血藤、鹿茸、杜仲、黄芪、当归、何首乌、冬虫夏草、木糖醇混合,得原料混合物。
步骤2、向原料混合物中加入纯净水进行均质。均质后过滤(300目)。
步骤3、向过滤后的混合液中加入苹果酸,调节体系的pH值为6.5。
步骤4、在125℃的温度下进行灭菌(转速为每分钟15转,出口温度65℃),然后降温至35℃灌装,最后用微波二次灭菌(转速为每分钟15转,出口温度65℃),检质,贴标,装箱。
所述步骤2中的纯净水温度为67℃。
所述步骤2中均质压力为30Mpa。
为进一步说明本发明的有益效果,以下提供临床应用报告中的试验案例。
试验例1。
分为三组,即空白组、实验组与汇仁肾宝对照组,每日一次,连续10日。汇仁肾宝对照组采用每日灌服1ml/kg(低剂量组)、4ml/kg(中剂量组)和8ml/kg(高剂量组)的汇仁肾宝。空白组给予蒸馏水(8ml/kg)。实验组采用本实施例1的补肾壮阳饮料,每日灌服1ml/kg(低剂量组)、4ml/kg(中剂量组)和8ml/kg(高剂量组),可明显增加去势雄性小鼠爬背率和爬背次数;实验组的高剂量组还能减轻去势雄鼠的会阴复合体和前列腺等附性腺器官的萎缩。这些均说明本发明的补肾壮阳饮料有一定的提高性功能作用,具体结果见表1。
表1:各组小鼠爬背率与爬背次数。
| 组别 | 剂量ml/kg | 爬背率% | 爬背次数 次/h |
| 实验组低剂量组 | 1 | 12 | 3 |
| 实验组中剂量组 | 4 | 38 | 5 |
| 实验组高剂量组 | 8 | 100 | 10 |
| 对照组低剂量组 | 1 | 10 | 1 |
| 对照组中剂量组 | 4 | 20 | 3 |
| 对照组高剂量组 | 8 | 40 | 5 |
| 空白组 | 8 | 0 | 0 |
试验例2。
本发明对改善人体免疫功能的临床疗效。
1、患者200例:免疫功能低下,易感冒,平均每月二次以上。随机分为两组,即实验组100例与对照组100例。
2、服用方法及疗程:(1)实验组口服本实施例1的补肾壮阳饮料,一日三次,每次20ml,以一个月为疗程。(2)对照组口服虫草胶囊每次三粒。
3、疗效评价,结果见表2。由表2可知,本实施例1的补肾壮阳饮料能改善人体免疫功能。
表2:人体免疫功能的临床改善情况。
| 例数 | 明显改善 | 改善 | 无效 | 总改善率% | |
| 实验组 | 100 | 80 | 12 | 8 | 92 |
| 对照组 | 100 | 50 | 30 | 20 | 80 |
试验例3。
分为三组,即空白组、汇仁肾宝对照组、实验组。汇仁肾宝对照组服用10ml/kg的汇仁肾宝。空白组服用10ml/kg蒸馏水。实验组服用10ml/kg的本实施例1补肾壮阳饮料。每日一次,连续10日,试验开始第一天,于末次给药后1小时,将小鼠放入15±1℃的游泳槽中,观察小鼠放入水中沉至水底再无力浮起的时间为持续游泳时间,结果见表3。由表3可知,本实施例1的补肾壮阳饮料可明显延长小鼠低温持续游泳时间。
表3:各组小鼠低温游泳平均存活时间。
| 组别 | 剂量(ml/kg) | 低温游泳平均存活时间(min) |
| 实验组 | 10 | 14.1 |
| 对照组 | 10 | 8.6 |
| 空白对照 | 10 | 5.8 |
典型病例。
1、赵某,男,43岁,性机能减退,二个月房事一次,并且房事后浑身酸痛,四肢无力,头晕耳鸣。服用本实施例1补肾壮阳饮料,一日三次,每次20mL,二个月后性机能有所提高,症状减退,连续服用六个月后性机能恢复正常,平均每周一次房事,并且房事后身体酸痛感、头晕耳鸣症状消失,精神饱满。
2、陈某,男,35岁,精神性阳痿,硬而不坚,性交成功率低。服用本实施例1补肾壮阳饮料,一日三次,每次30mL。连续服用二个月情况有所改变,服用六个月阳痿现象消失,阴茎勃起大于90度,性交成功率大于85%。
实施例2。
本实施例2提供一种补肾壮阳饮料,是由如下重量份数的原料组成的:蓝莓20份、红枣15份、鸸鹋阳10份、枸杞子15份、人参12份、山药18份、肉桂15份、芡实10份、韭菜籽15份、红景天15份、女贞子12份、鸡血藤10份、鹿茸15份、杜仲13份、黄芪11份、当归20份、何首乌15份、冬虫夏草11份、木糖醇15份、苹果酸12份、纯净水90份。
本实施例2还提供一种补肾壮阳饮料的制备方法,包括如下步骤:
步骤1、按配方比例将蓝莓、红枣、鸸鹋阳、枸杞子、人参、山药、肉桂、芡实、韭菜籽、红景天、女贞子、鸡血藤、鹿茸、杜仲、黄芪、当归、何首乌、冬虫夏草、木糖醇混合,得原料混合物。
步骤2、向原料混合物中加入纯净水进行均质。均质后过滤(300目)。
步骤3、向过滤后的混合液中加入苹果酸,调节体系的pH值为6.2。
步骤4、在125℃的温度下进行灭菌,然后降温至30℃灌装,最后用微波二次灭菌,检质,贴标,装箱。
所述步骤2中的纯净水温度为66℃。
所述步骤2中均质压力为25Mpa。
实施例3。
本实施例3提供一种补肾壮阳饮料,是由如下重量份数的原料组成的:蓝莓25份、红枣20份、鸸鹋阳15份、枸杞子25份、人参18份、山药20份、肉桂25份、芡实10份、韭菜籽25份、红景天15份、女贞子15份、鸡血藤20份、鹿茸25份、杜仲20份、黄芪20份、当归15份、何首乌22份、冬虫夏草15份、木糖醇20份、苹果酸15份、纯净水140份。
本实施例3还提供一种补肾壮阳饮料的制备方法,包括如下步骤。
步骤1、按配方比例将蓝莓、红枣、鸸鹋阳、枸杞子、人参、山药、肉桂、芡实、韭菜籽、红景天、女贞子、鸡血藤、鹿茸、杜仲、黄芪、当归、何首乌、冬虫夏草、木糖醇混合,得原料混合物。
步骤2、向原料混合物中加入纯净水进行均质。均质后过滤(300目)。
步骤3、向过滤后的混合液中加入苹果酸,调节体系的pH值为6.6。
步骤4、在125℃的温度下进行灭菌,然后降温至39℃灌装,最后用微波二次灭菌,检质,贴标,装箱。
所述步骤2中的纯净水温度为67℃。
所述步骤2中均质压力为34Mpa。
Claims (8)
1.一种补肾壮阳饮料,其特征在于,是由如下原料组成的:蓝莓10-30份、红枣8-20份、鸸鹋阳5-20份、枸杞子10-30份、人参5-20份、山药10-25份、肉桂10-30份、芡实5-15份、韭菜籽10-30份、红景天10-30份、女贞子10-40份、鸡血藤10-30份、鹿茸10-30份、杜仲10-35份、黄芪10-30份、当归10-40份、何首乌10-30份、冬虫夏草5-20份、木糖醇5-30份、苹果酸5-20份、纯净水26-150份。
2.如权利要求1所述的补肾壮阳饮料,其特征在于,是由如下重量份数的原料组成的:蓝莓10份、红枣8份、鸸鹋阳5份、枸杞子10份、人参10份、山药10份、肉桂10份、芡实8份、韭菜籽10份、红景天10份、女贞子10份、鸡血藤10份、鹿茸10份、杜仲10份、黄芪10份、当归10份、何首乌10份、冬虫夏草8份、木糖醇10份、苹果酸8份、纯净水95份。
3.如权利要求2所述的补肾壮阳饮料,其特征在于,是由如下原料组成的:蓝莓20份、红枣15份、鸸鹋阳10份、枸杞子15份、人参12份、山药18份、肉桂15份、芡实10份、韭菜籽15份、红景天15份、女贞子12份、鸡血藤10份、鹿茸15份、杜仲13份、黄芪11份、当归20份、何首乌15份、冬虫夏草11份、木糖醇15份、苹果酸12份、纯净水9份。
4.如权利要求3所述的补肾壮阳饮料,其特征在于,是由如下重量份数的原料组成的:蓝莓25份、红枣20份、鸸鹋阳15份、枸杞子25份、人参18份、山药20份、肉桂25份、芡实10份、韭菜籽25份、红景天15份、女贞子15份、鸡血藤20份、鹿茸25份、杜仲20份、黄芪20份、当归15份、何首乌22份、冬虫夏草15份、木糖醇20份、苹果酸15份、纯净水140份。
5.如权利要求1所述的补肾壮阳饮料的制备方法,其特征在于,包括如下步骤:
步骤1、按配方比例将蓝莓、红枣、鸸鹋阳、枸杞子、人参、山药、肉桂、芡实、韭菜籽、红景天、女贞子、鸡血藤、鹿茸、杜仲、黄芪、当归、何首乌、冬虫夏草、木糖醇混合,得原料混合物;
步骤2、向原料混合物中加入纯净水进行均质,均质后过滤(300目);
步骤3、向过滤后的混合液中加入苹果酸,调节体系的pH值为6.0-6.8;
步骤4、在125℃的温度下进行灭菌,然后降温、灌装,最后用微波二次灭菌,检质,贴标,装箱。
6.如权利要求5所述的补肾壮阳饮料的制备方法,其特征在于,所述步骤2中的纯净水温度为65-70℃。
7.如权利要求5所述的补肾壮阳饮料的制备方法,其特征在于,所述步骤2中均质压力为25-35Mpa。
8.如权利要求5所述的补肾壮阳饮料的制备方法,其特征在于,所述步骤4中降温至30-40℃。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510773980.3A CN105232907A (zh) | 2015-11-13 | 2015-11-13 | 一种补肾壮阳饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510773980.3A CN105232907A (zh) | 2015-11-13 | 2015-11-13 | 一种补肾壮阳饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105232907A true CN105232907A (zh) | 2016-01-13 |
Family
ID=55030901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510773980.3A Pending CN105232907A (zh) | 2015-11-13 | 2015-11-13 | 一种补肾壮阳饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105232907A (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943709A (zh) * | 2016-06-25 | 2016-09-21 | 张阳康 | 一种补肾壮阳保健茶及其生产工艺 |
| CN106509863A (zh) * | 2016-01-22 | 2017-03-22 | 山东源密码生物科技有限责任公司 | 一种男性专用功能性保健口服液益阳菌及其制备方法 |
| CN107232532A (zh) * | 2017-06-18 | 2017-10-10 | 合肥睿联生物科技有限公司 | 一种虾仁补肾壮阳地瓜叶丸子及其制备方法 |
| CN108244436A (zh) * | 2018-02-09 | 2018-07-06 | 李冠楠 | 一种参茸饮料及其制备方法和用途 |
| CN110338428A (zh) * | 2019-07-04 | 2019-10-18 | 山东薇薇朵生物科技有限公司 | 人参低聚肽在制备改善和增强性功能的食品或保健食品中的用途 |
| CN115177684A (zh) * | 2022-08-10 | 2022-10-14 | 高兆爱 | 一种滋阴补肾的中药组合物 |
-
2015
- 2015-11-13 CN CN201510773980.3A patent/CN105232907A/zh active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106509863A (zh) * | 2016-01-22 | 2017-03-22 | 山东源密码生物科技有限责任公司 | 一种男性专用功能性保健口服液益阳菌及其制备方法 |
| CN105943709A (zh) * | 2016-06-25 | 2016-09-21 | 张阳康 | 一种补肾壮阳保健茶及其生产工艺 |
| CN107232532A (zh) * | 2017-06-18 | 2017-10-10 | 合肥睿联生物科技有限公司 | 一种虾仁补肾壮阳地瓜叶丸子及其制备方法 |
| CN108244436A (zh) * | 2018-02-09 | 2018-07-06 | 李冠楠 | 一种参茸饮料及其制备方法和用途 |
| CN110338428A (zh) * | 2019-07-04 | 2019-10-18 | 山东薇薇朵生物科技有限公司 | 人参低聚肽在制备改善和增强性功能的食品或保健食品中的用途 |
| CN115177684A (zh) * | 2022-08-10 | 2022-10-14 | 高兆爱 | 一种滋阴补肾的中药组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
| CN103263608B (zh) | 一种排毒养颜的中药原粉 | |
| CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
| CN105233010A (zh) | 一种补肾壮阳酒及其制备方法 | |
| CN105362501A (zh) | 一种防辐射保护视力的饮料及其制备方法 | |
| CN105232907A (zh) | 一种补肾壮阳饮料及其制备方法 | |
| CN105233100A (zh) | 一种治疗糖尿病的饮料及其制备方法 | |
| CN106214989A (zh) | 一种抗衰老、改善记忆力的鹿血保健药酒及其制备方法 | |
| CN103520621B (zh) | 一种治疗老年性白内障的中药组合物及其制备方法 | |
| CN102614444B (zh) | 一种有效治疗酒醉综合症的口服液 | |
| CN104673578B (zh) | 具有保健功效的sod葡萄酒及制备方法 | |
| CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
| CN1142785C (zh) | 抗疲劳胶囊 | |
| CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
| CN107837343A (zh) | 一种缓解眼疲劳、治疗近视的复方中药组合物及其丸剂的制备方法 | |
| CN103525640B (zh) | 一种活力壮阳酒 | |
| CN103520643B (zh) | 一种用于治疗糖尿病白内障的中药制剂及其制备方法 | |
| CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
| CN101244154B (zh) | 用于优生优育预防出生缺陷并改善记忆的药物组合物 | |
| CN1279949C (zh) | 一种轻身益寿中药 | |
| CN105028832A (zh) | 一种可缓解眼部疲劳的蓝莓茶及其制备方法 | |
| CN114748583A (zh) | 一种滋补养生的中药药酒 | |
| CN105214068B (zh) | 一种治疗小儿多发性抽动症的营养组合物及其制备方法 | |
| CN108126161A (zh) | 一种治疗高血压的中草药及其制备方法和应用 | |
| CN102250736A (zh) | 一种保健药酒及其制造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160113 |
|
| WD01 | Invention patent application deemed withdrawn after publication |